DNER and cancer: In recent years, in a variety of cancer mice models, bromodomain and extraterminal protein inhibitors (BETi) prevented the recruitment of bromodomain and extraterminal protein (BET) protein to chromatin and inhibit BET transcriptional activity by selectively targeting the epigenetic reader of BET family [202–204].